Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Merck Kgaa (MKGAF)

Merck Kgaa (MKGAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Merck Kgaa Frankfurter Strasse 250 Darmstadt 2M 64293 DEU

www.merckgroup.com Employees: 62,908 P: 49-61-517-20

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

Key Statistics

Overview:

Market Capitalization, $K 21,873,870
Enterprise Value, $K 30,487,890
Shares Outstanding, K 129,240
Float, K 0
% Float 0.00%
Short Interest, K 1,115
Short Float 0.00%
Days to Cover 761.70
Short Volume Ratio 0.49

Financials:

Annual Sales, $ 22,721 M
Annual Net Income, $ 3,056 M
Last Quarter Sales, $ 5,764 M
Last Quarter Net Income, $ 653,680 K
EBIT, $ 3,603 M
EBITDA, $ 5,638 M

Growth:

1-Year Return 7.73%
3-Year Return -22.39%
5-Year Return -5.16%
5-Year Revenue Growth 29.67%
5-Year Earnings Growth 52.66%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.51 on 08/01/24
Next Earnings Date 11/14/24
Earnings Per Share ttm 7.09
EPS Growth vs. Prev Qtr -13.22%
EPS Growth vs. Prev Year -37.08%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 05/12/14
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 06/30/14

MKGAF Ratios

Ratio
Price/Earnings ttm 23.55
Price/Earnings forward 17.13
Price/Earnings to Growth N/A
Return-on-Equity % 10.17%
Return-on-Assets % 5.74%
Profit Margin % 13.45%
Debt/Equity 0.38
Price/Sales 0.95
Price/Cash Flow 3.20
Price/Book 0.70
Book Value/Share 238.44
Interest Coverage 11.82
60-Month Beta 0.96
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar